Navigation Links
Microfluidics Promotes Scientific University Research Using Nanotechnology with Innovation Incentives
Date:5/17/2010

nologies
  • Courtesy “Lunch n' Learn” on-campus seminars
  • Preferred rental arrangements where applicable
  • Beta site, demonstration and publication opportunities

  • “Partnering with Microfluidics has enabled us to advance exciting new nanotechnology-based methods for drug delivery, for example, to penetrate the blood brain barrier,” said Mansoor Amiji, Ph.D., Distinguished Professor and Chair of Pharmaceutical Sciences at Northeastern University. “This is the only technology successful thus far in creating decorated drug nanoparticles which deliver benefits to specific parts of the body and, therefore, accomplish more with less drug.”

    “As you reduce the particle size of your formulation containing the compound of interest, you increase its surface area, thereby improving bioavailability and efficacy and, as a result, reducing adverse side effects by decreasing the required dose for effectiveness,” explained Prof. Robert Nicolosi, Ph.D., of the Department of Clinical Laboratory & Nutritional Sciences at University of Massachusetts Lowell. “Microfluidics provides an enabling technology which has allowed us to develop novel properties for pharmaceutical, nutraceutical and cosmeceutical applications.”

    More than one in every ten Microfluidizer processors sold are to universities – a figure Microfluidics expects to increase over time as the core model for biopharmaceutical R&D continues to evolve. The recently launched LV1 low volume processor, which for the first time brings Microfluidizer-quality processing capabilities to samples as small as 1 ml, is an ideal solution for universities with limited or high value raw materials.

    “The importance of academic research to the pharmaceutical industry's drug development strategy cannot be understated, and it's increasing every day,” said Michael C. Ferrara, Mic
    '/>"/>

    Source: PRWeb
    Copyright©2010 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. New 'Stop Drinking 411' Campaign Promotes Alcohol Recovery and Prevention via Web Social Media
    2. New STOP DRINKING 411 Campaign Promotes Alcohol Recovery and Prevention Via Web Social Media
    3. AAHFN Promotes Heart Failure Awareness Week Through Webinar
    4. UM School of Medicine scientists find new malaria vaccine is safe and promotes immune response in children
    5. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
    6. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
    7. Medical Transcription Services and EHR Provider MxSecure Promotes Tim Erkel to VP, Client Services
    8. Hearts and Minds Promotes Wellness; African Americans Living with Mental Illness Have Higher Risk for Other Illnesses.
    9. Pinstripe Promotes Jill Schwieters to President of Pinstripe Healthcare
    10. Scientific exchange program promotes collaborative quality standards for drugs, food ingredients
    11. Scientists find key to gene that promotes cancer metastasis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... New York, NY (PRWEB) , ... September 01, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – today announced its annual Light it Red for Lymphoma awareness ...
    (Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Philanthropic giving ... awareness of societal issues and needs. Money for Good 2015, released today by Camber ... it. There’s an annual potential to mobilize up to $22B in new philanthropic giving ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... of the American Society for Dermatologic Surgery, according to a new survey that ... Consumer Survey on Cosmetic Dermatologic Procedures – which reflects views on cosmetic medical ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
    (Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic ... ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over the past ... than $13.5 million for programs and services designed to support patients and their families ...
    Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3
    ... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... for Fluocinonide Cream 0.1%, a generic version of,VANOS(R) Cream ... to file an,ANDA with a Paragraph IV certification against ... (steroid,hormone) approved to relieve the inflammation and itching caused ...
    ... rosiglitazone showed 59.5% reduced risk of retina damage , , ... may slow the progression of eye disease in diabetes ... Eye Institute at the University of California, Los Angeles. ... the drug were less likely to develop proliferative diabetic ...
    ... say it will be several years before there,s widespread ... sophisticated new imaging device could one day help doctors ... earlier and more accurately, researchers report. , If left ... sudden or acute glaucoma attack, which can result in ...
    ... Results from five pivotal phase 3 studies of ... Association (ADA) 68th Scientific Sessions by Takeda Global ... has been shown to be a highly selective ... investigation as an oral treatment for type 2 ...
    ... June 9 Today, Earvin "Magic",Johnson ( ... (NYSE: ABT ) and the Magic ... as part of the,"I Stand With Magic ... Black HIV/AIDS,",directed by Academy Award-nominated director Spike ...
    ... U.S.,Fund for UNICEF and global pharmaceutical company, Merck & ... of M-M-R(R) II,(measles, mumps and rubella virus vaccine, live, ... Moldova, in response to an,ongoing serious mumps outbreak in ... against three diseases, measles,mumps, and rubella, and will be ...
    Cached Medicine News:Health News:Perrigo Confirms Filing for Generic Version of VANOS(R) 2Health News:Diabetes Drug May Slow Eye Disease 2Health News:New Imaging Tool Can Spot Glaucoma Risk 2Health News:New Imaging Tool Can Spot Glaucoma Risk 3Health News:Phase 3 results for alogliptin 2Health News:Phase 3 results for alogliptin 3Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 2Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 3Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 4Health News:UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic 2Health News:UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic 3
    (Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
    (Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
    (Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
    Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
    ... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
    ... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
    Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
    ... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
    ... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
    Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
    Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
    Medicine Products: